| Lizenz: Creative Commons Namensnennung 4.0 International (237kB) |
- URN zum Zitieren dieses Dokuments:
- urn:nbn:de:bvb:355-epub-380727
- DOI zum Zitieren dieses Dokuments:
- 10.5283/epub.38072
Zusammenfassung
Gliomas are highly invasive brain tumors with short patient survival. One major pathogenic factor is aberrant tumor metabolism, which may be targeted with different specific and unspecific agents. Drug repurposing is of increasing interest in glioma research. Drugs interfering with the patient’s metabolism may also influence glioma metabolism. In this review, we outline definitions and methods ...
Nur für Besitzer und Autoren: Kontrollseite des Eintrags